Skip navigation
HKU Login
Guest Login
Home
Publications
Researchers
Staff
Research Postgraduates
Organizations
Grants
Datasets
Deposit Data
HKUL Research Data Management
Theses
Patents
Community Service
Browsing by Author Leung, LKS
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
中
or enter first few letters:
Showing results 1 to 9 of 9
Title
Author(s)
Issue Date
Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong
Journal:
PharmacoEconomics - Open
Loong, HHF
Wong, CKH
Leung, LKS
Dhankhar, P
Insinga, RP
Chandwani, S
Hsu, DC
Lee, MYK
Huang, M
Pellissier, J
Rai, A
Achra, M
Tan, SC
2020
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong
Journal:
Cost Effectiveness and Resource Allocation
Loong, HH
Wong, CKH
Leung, LKS
Chan, CPK
Chang, A
Zhou, ZY
Xie, J
Gibbs, M
2020
Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong
Journal:
Cost Effectiveness and Resource Allocation
Loong, HH
Wong, CKH
Leung, LKS
Tan, SC
Jen, J
Lee, MYK
Aguiar-Ibáñez, R
Wang, J
2020
Cost-effectiveness of ceritinib in previously untreated ALK-positive advanced non-small cell lung cancer in Hong Kong
Proceeding/Conference:
ESMO Asia Congress
Loong, HHF
Wong, CKH
Leung, LKS
Chan, CPK
Chang, A
Gibbs, M
2018
Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong
Proceeding/Conference:
Annals of Oncology
Loong, HHF
Wong, CKH
Leung, LKS
Leung, MTK
Wang, J
Stevinson, K
2016
Neutrophil-lymphocyte and platelet-lymphocyte ratios as robust prognostic markers in sarcomas: A population-based analysis of 3746 sarcoma patients from Hong Kong
Proceeding/Conference:
Annals of Oncology
Kwan, SCS
Wong, CKH
Ho, CW
Zhang, YZ
Tse, T
Lau, YM
Leung, LKS
Tan, T
Loong, H
2019
Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas
Journal:
ESMO Open
Loong, HHF
Wong, CKH
Wei, Y
Kwan, SSC
Zhang, Y
Tse, T
Lau, YM
Leung, LKS
Tang, GCH
2020
Prevalence and prognostic impact of comorbidities in sarcomas: A population-based study of 3746 patients in Hong Kong
Proceeding/Conference:
Annals of Oncology
Loong, HHF
Wong, CKH
Ho, CW
Tse, T
Kwan, SSC
Lau, YM
Leung, LKS
2019
Prevalence of chemotherapy use and its impact on overall survival in patients with bone and soft tissue sarcomas: A population-based analysis of 3746 patients
Proceeding/Conference:
Annals of Oncology
Loong, HHF
Wong, CKH
Ho, CW
Leung, LKS
Tse, T
Kwan, SS
Lau, YM
2019